biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by lovincoalon Mar 10, 2017 9:06pm

211 Views

Post# 25966967

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Fear Fongering

And then you have the temerity to ridicule me because I tried to post good information and sound opinions, and tried to stop you from hurting us all as you have.

JD, as I've stated both publicly and privately I respect and appreciate you AND all the info you post and the hard work & research you do - truly, I'm being serious. I've never criticized you personally nor ridiculed you. In my last post I was simply and honestly asking if you realistically thought (when you said it) that it would go to .75 or was that said in frustration and anger (at other posters). I remember it was a "tense" and frustrating time for all shareholders with the share price falling so saying something in anger/frustration/etc. would have been perfectly normal. I still believe in the science for BTI's technology but did have my own, negative, opinions about the way management had handled certain things. I'm just a shareholder so I don't know what hurdles they are facing or what progress (until it is announced) they are making. Simply stating my questions and opinion about executive operation shouldn't be construed as damning the company, all the execs & employees and their technology and as a result cratering the share price and hurting us all.

I have focussed a lot on "who is doing the selling & why" and maybe we'll never know the answer to that and it could have nothing to do with anything the company is or isn't doing - the reason could be as simple as a shareholder dying and the estate selling their shares or a divorce or a number of other reasons.

I'll sit back now, no need to post my same questions again and again. I do believe the company will do great things eventually (I've learned the hard way that anything in the biotech space takes much longer than you think) and the share price will be multiples of where it is today. I'm sure sentiment at Apple and with their shareholders wasn't great when it was trading around $10 not that many years ago and look where it is now :)

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features